Evidence map›Paper›PMID 24941001›Full record

ArticlePloS one2014

Molecular hydrogen attenuates neuropathic pain in mice.

Masanori Kawaguchi, Yasushi Satoh, Yukiko Otsubo, Tomiei Kazama

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05476575 (The Effect of Perioperative Hydrogen Inhalation on Post-operative Pain and Inflammation Cytokines), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05476575 nacompletednot on this mapstarted 2021, after this paper: background citation

The Effect of Perioperative Hydrogen Inhalation on Post-operative Pain and Inflammation Cytokines

TypeinterventionalSponsorFu Jen Catholic University HospitalRan2021 to 2022Enrolled37ConditionsPain, AcuteArmshydrogen inhalation, 4% concentration, given via nasal cannula
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Redox reactions in chronic pain: mechanisms and relevance in fibromyalgia.Frontiers in pain research (Lausanne, Switzerland) · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Masanori KawaguchiDepartment of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan.
Yasushi SatohDepartment of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan.
Yukiko OtsuboDepartment of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan.
Tomiei KazamaDepartment of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan.
National Defense Medical College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropathic pain remains intractable and the development of new therapeutic strategies are urgently required. Accumulating evidence indicates that overproduction of oxidative stress is a key event in the pathogenesis of neuropathic pain. However, repeated intra-peritoneal or intrathecal injections of antioxidants are unsuitable for continuous use in therapy. Here we show a novel therapeutic method against neuropathic pain: drinking water containing molecular hydrogen (H2) as antioxidant. The effect of hydrogen on neuropathic pain was investigated using a partial sciatic nerve ligation model in mice. As indicators of neuropathic pain, temporal aspects of mechanical allodynia and thermal hyperalgesia were analysed for 3 weeks after ligation. Mechanical allodynia and thermal hyperalgesia were measured using the von Frey test and the plantar test, respectively. When mice were allowed to drink water containing hydrogen at a saturated level ad libitum after ligation, both allodynia and hyperalgesia were alleviated. These symptoms were also alleviated when hydrogen was administered only for the induction phase (from day 0 to 4 after ligation). When hydrogen was administered only for the maintenance phase (from day 4 to 21 after ligation), hyperalgesia but not allodynia was alleviated. Immunohistochemical staining for the oxidative stress marker, 4-hydroxy-2-nonenal and 8-hydroxydeoxyguanosine, showed that hydrogen administration suppressed oxidative stress induced by ligation in the spinal cord and the dorsal root ganglion. In conclusion, oral administration of hydrogen water may be useful for alleviating neuropathic pain in a clinical setting.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAldehydesAnalgesicsAnimalsAntioxidantsDeoxyguanosineDrinking WaterGanglia, SpinalHydrogenHyperalgesiaMiceMice, Inbred C57BLNeuralgiaOxidative StressPain MeasurementPeripheral Nerve Injuries4-hydroxy-2-nonenal8-Hydroxy-2'-DeoxyguanosineAldehydesAnalgesicsAntioxidantsDeoxyguanosineDrinking WaterHydrogen

Identifiers

PMID24941001
PMCPMC4062523
OpenAlexW2055297625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.